Skip to main content
Caplight Logo









Biosphere

Biosphere

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://www.biosphere.io/

Last Round

Grant

May 5, 2026

Total Funding Raised

$17.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biosphere is a biotechnology company that develops and manufactures UV-enabled bioreactor systems designed to reduce the capital intensity of industrial biomanufacturing for products such as therapeutics, enzymes, proteins, bioplastics, and fertilizers.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Defense Tech, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

bioreactorindustrial fermentationbiomanufacturingmodular bioreactorUV sterilizationgas fermentationbiotech hardwaredefense biomanufacturingfield-deployable biomanufacturingbioprocessingsynthetic biology hardwarebiotech infrastructureother transaction authorityOTAdual-use biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biosphere Comparables

Compare Biosphere with similar companies based on industry and business-model similarity.

Biosphere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Curve
80%
InFamily Foods
78%
Fermeate
71%

Biosphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 5, 2026
SeedJan 9, 2025

Key People

Founding team and executive leadership

Brian Heligman

Cofounder, CEO

Founding Team

Biosphere Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Grew 24% QoQ, from 21 to 26 employees.

  • Jul 17, 2026

    Grew 28% QoQ, from 18 to 23 employees.

Recent news

Latest coverage and updates

  • is_developingJun 30, 2026

    Biosphere is developing modular biomanufacturing systems capable of producing nutrition in austere environments on Jun 30th '26.

Biosphere Filings

Explore SEC and related filing metadata, where available.

Biosphere filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biosphere's valuation, stock price, and market status.

Is Biosphere a public or private company?

Biosphere is a private company.

What is the current stock price of Biosphere?

Biosphere is a private company with no public stock price. No recent secondary market data is available.

How much is Biosphere worth (valuation)?

Valuation information for Biosphere is not publicly available.

Can I buy Biosphere stock?

Biosphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biosphere's last funding round?

Biosphere's most recent funding round was Seed on January 9, 2025.

Who are the main investors in Biosphere?

Key investors in Biosphere include VXI Capital, Lowercarbon Capital.

Will Biosphere IPO soon?

No public IPO plans have been announced for Biosphere.

How can I track Biosphere secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biosphere's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOakland, California
Employee Range26
Year Founded2022
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?